China Shineway Pharmaceutical Group financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$703.58M | HK$831.38M | HK$841.48M | HK$1.01B | HK$1.28B | HK$1.63B | HK$2.04B | HK$1.98B | HK$2.13B | HK$2.19B | HK$2.23B | HK$2.05B | HK$1.99B | HK$1.92B | HK$2.57B | HK$2.71B | HK$2.66B | HK$3.22B | HK$3.95B | HK$4.52B | HK$0.00M |
| GM % | Gross Margin % |
|
64.18% | 66.95% | 70.39% | 72.86% | 71.70% | 72.13% | 70.40% | 65.61% | 65.28% | 67.41% | 66.30% | 66.23% | 64.54% | 66.01% | 72.99% | 73.23% | 74.85% | 74.77% | 74.38% | 75.15% | 0.00% |
| OM | Operating Margin |
|
39.79% | 39.00% | 40.49% | 39.40% | 42.20% | 40.13% | 42.50% | 38.30% | 30.38% | 31.55% | 31.42% | 29.89% | 28.32% | 21.26% | 19.23% | 17.60% | 16.17% | 16.58% | 18.06% | 21.48% | 0.00% |
| EPS | Earnings Per Share |
|
HK$0.40 | HK$0.40 | HK$0.39 | HK$0.48 | HK$0.93 | HK$0.99 | HK$0.91 | HK$0.78 | HK$0.83 | HK$0.85 | HK$0.80 | HK$0.71 | HK$0.55 | HK$0.62 | HK$0.69 | HK$0.66 | HK$0.74 | HK$0.96 | HK$1.28 | HK$0.00 | |
| Div. | Dividends |
|
HK$0.00 | HK$0.10 | HK$0.22 | HK$0.23 | HK$0.25 | HK$0.37 | HK$0.40 | HK$0.37 | HK$0.32 | HK$0.33 | HK$0.33 | HK$0.32 | HK$0.32 | HK$0.32 | HK$0.32 | HK$0.23 | HK$0.32 | HK$0.39 | HK$0.32 | HK$0.44 | HK$0.00 |
| PR % | Payout Ratio % |
|
0 | 25.00% | 55.00% | 58.97% | 52.08% | 39.78% | 40.40% | 40.66% | 41.03% | 39.76% | 38.82% | 40.00% | 45.07% | 58.18% | 51.61% | 33.33% | 48.48% | 52.70% | 33.33% | 34.38% | 0 |
| Sha. | Shares |
|
800m | 830m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 827m | 816.85m | 773.4m | 754.6m | 754.6m | 755.4m | 755.4m | 755.4m |
| OCF | Operating Cash Flow |
|
HK$230.55M | HK$452.25M | HK$417.41M | HK$401.97M | HK$405.28M | HK$1.06B | HK$579.43M | HK$485.06M | HK$635.67M | HK$519.89M | HK$773.16M | HK$744.71M | HK$733.53M | HK$490.65M | HK$532.59M | HK$368.00M | HK$638.57M | HK$703.15M | HK$1.11B | HK$932.64M | HK$0.00M |
| FCF | Free Cash Flow |
|
HK$208.19M | HK$379.20M | HK$394.19M | HK$315.64M | HK$321.12M | HK$881.12M | HK$283.84M | HK$88.48M | HK$268.01M | HK$258.00M | HK$668.98M | HK$643.25M | HK$627.58M | HK$398.82M | HK$405.25M | HK$279.60M | HK$572.54M | HK$609.52M | HK$980.22M | HK$433.00M | HK$0.00M |
| FCFS | Free Cash Flow Per Share |
|
HK$0.34 | HK$0.46 | HK$0.48 | HK$0.37 | HK$0.39 | HK$1.01 | HK$0.25 | HK$0.11 | HK$0.32 | HK$0.31 | HK$0.75 | HK$0.75 | HK$0.76 | HK$0.48 | HK$0.48 | HK$0.35 | HK$0.76 | HK$0.81 | HK$1.30 | HK$1.04 | HK$0.00 |